{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:37:01Z","timestamp":1789511821388,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-024-05368-2","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T15:51:25Z","timestamp":1735228285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antifungal susceptibility profile of Candida species and uncommon yeasts from drug abusers with oral candidiasis"],"prefix":"10.1186","volume":"24","author":[{"given":"Aynaz","family":"Ghojoghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Khodavaisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Zarei Mahmoudabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Fatahinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"issue":"4","key":"5368_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejpsy.2019.07.001","volume":"33","author":"PC Barata","year":"2019","unstructured":"Barata PC, Oliveira C, de Castro SL, da Mota AR. A systematic review on Substance Addiction: medical diagnosis or morality flaw? Eur J Psychiatry. 2019;33(4):143\u201351. https:\/\/doi.org\/10.1016\/j.ejpsy.2019.07.001.","journal-title":"Eur J Psychiatry"},{"key":"5368_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","volume":"6","author":"S Roy","year":"2011","unstructured":"Roy S, Ninkovic J, Banerjee S, Charboneau RG, Das S, Dutta R, Kirchner VA, Koodie L, Ma J, Meng J. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol. 2011;6:442\u201365. https:\/\/doi.org\/10.1007\/s11481-011-9292-5.","journal-title":"J Neuroimmune Pharmacol"},{"key":"5368_CR3","doi-asserted-by":"publisher","first-page":"102656","DOI":"10.1016\/j.drugpo.2019.102656","volume":"77","author":"S Larney","year":"2020","unstructured":"Larney S, Leung J, Grebely J, Hickman M, Vickerman P, Peacock A, Stone J, Trickey A, Dumchev KV, Colledge S. Global systematic review and ecological analysis of HIV in people who inject drugs: national population sizes and factors associated with HIV prevalence. Int J Drug Policy. 2020;77:102656. https:\/\/doi.org\/10.1016\/j.drugpo.2019.102656.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"5368_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/add.14393","volume":"114","author":"J Grebely","year":"2019","unstructured":"Grebely J, Larney S, Peacock A, Colledge S, Leung J, Hickman M, Vickerman P, Blach S, Cunningham EB, Dumchev K. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction. 2019;114(1):150\u201366. https:\/\/doi.org\/10.1111\/add.14393.","journal-title":"Addiction"},{"issue":"2","key":"5368_CR5","doi-asserted-by":"publisher","first-page":"e1323","DOI":"10.1002\/hpm.2800","volume":"34","author":"M Nekoei-Moghadam","year":"2019","unstructured":"Nekoei-Moghadam M, Heidari N, Amiresmaeili M, Heidarijamebozorgi M. Prioritizing the health problems of slum residents using social determinants of health: a case study in a developing country. Int J Health Plann Manag. 2019;34(2):e1323\u201333. https:\/\/doi.org\/10.1002\/hpm.2800.","journal-title":"Int J Health Plann Manag"},{"issue":"87","key":"5368_CR6","first-page":"22","volume":"22","author":"K Hajian","year":"2013","unstructured":"Hajian K, Khirkhah F, Falatoni M. Epidemiology of addiction among volunteered addicts attending in detoxification centers. J Guilan Univ Med Scienc. 2013;22(87):22\u201330.","journal-title":"J Guilan Univ Med Scienc"},{"issue":"3","key":"5368_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1099\/00222615-23-3-275","volume":"23","author":"F Odds","year":"1987","unstructured":"Odds F, Palacio-Hernanz A, Cuadra J, Sanchez J. Disseminated Candida infection syndrome in heroin addicts\u2014dominance of a single Candida albicans biotype. J Med Microbiol. 1987;23(3):275\u20137. https:\/\/doi.org\/10.1099\/00222615-23-3-275.","journal-title":"J Med Microbiol"},{"issue":"1","key":"5368_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12903-023-02969-1","volume":"23","author":"P Khalili","year":"2023","unstructured":"Khalili P, Movagharipoor A, Sardari F, Movaghari Pour F, Jamali Z. Oral candidiasis and cigarette, tobacco, alcohol, and opium consumption in Rafsanjan, a region in the southeast of Iran. BMC Oral Health. 2023;23(1):262. https:\/\/doi.org\/10.1186\/s12903-023-02969-1.","journal-title":"BMC Oral Health"},{"issue":"1","key":"5368_CR9","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/s41598-024-52105-4","volume":"14","author":"A Ghojoghi","year":"2024","unstructured":"Ghojoghi A, Khodavaisy S, Mahmoudabadi AZ, Nazar E, Fatahinia M. Exploring the diversity of uncommon oral yeast species and associated risk factors among substance abusers in southwestern Iran. Sci Rep. 2024;14(1):1906. https:\/\/doi.org\/10.1038\/s41598-024-52105-4.","journal-title":"Sci Rep"},{"issue":"7","key":"5368_CR10","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/jac\/dkt083","volume":"68","author":"F Guo","year":"2013","unstructured":"Guo F, Yang Y, Kang Y, Zang B, Cui W, Qin B, Qin Y, Fang Q, Qin T, Jiang D. Invasive candidiasis in intensive care units in China: a multicentre prospective observational study. J Antimicrob Chemother. 2013;68(7):1660\u20138. https:\/\/doi.org\/10.1093\/jac\/dkt083.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"5368_CR11","first-page":"6521","volume":"11","author":"D Sun","year":"2018","unstructured":"Sun D, Ye T, Ren P, Yu S. Prevalence and etiology of oral diseases in drug-addicted populations: a systematic review. Int J Clin Exp Med. 2018;11(7):6521\u201331.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"5368_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/bacteria3030015","volume":"3","author":"MM Esposito","year":"2024","unstructured":"Esposito MM, Kalinowski J, Mikhaeil M. The effects of recreational and Pharmaceutical Substance use on oral microbiomes and Health. Bacteria. 2024;3(3):209\u201322. https:\/\/doi.org\/10.3390\/bacteria3030015.","journal-title":"Bacteria"},{"issue":"7","key":"5368_CR13","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/odi.13246","volume":"26","author":"C Liu","year":"2020","unstructured":"Liu C, Qi X, Yang D, Neely A, Zhou Z. The effects of cannabis use on oral health. Oral Dis. 2020;26(7):1366\u201374. https:\/\/doi.org\/10.1111\/odi.13246.","journal-title":"Oral Dis"},{"key":"5368_CR14","doi-asserted-by":"publisher","unstructured":"Quaranta A, D\u2019Isidoro O, Piattelli A, Hui WL, Perrotti V. Illegal drugs and periodontal conditions. Periodontology. 2000 2022, 90(1):62\u201387. https:\/\/doi.org\/10.1111\/prd.12450","DOI":"10.1111\/prd.12450"},{"issue":"1","key":"5368_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5530\/jyp.2020.12.3","volume":"12","author":"LAR Valadas","year":"2020","unstructured":"Valadas LAR, Fernandes ML, Silva MIG, de Oliveira Cit\u00f3 MC, Oliveira ICM, Dias ML, de Mello Fiallos AC, Vasconcelos LF, dos Santos LKX, de Carvalho AMR. Oral manifestations of drug abuse: a review of literature. J Young Pharm. 2020;12(1):11. https:\/\/doi.org\/10.5530\/jyp.2020.12.3.","journal-title":"J Young Pharm"},{"issue":"11","key":"5368_CR16","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1021\/acsinfecdis.1c00424","volume":"7","author":"B Lin","year":"2021","unstructured":"Lin B, Li R, Handley TN, Wade JD, Li W, O\u2019Brien-Simpson NM. Cationic antimicrobial peptides are leading the way to combat oropathogenic infections. ACS Infect Dis. 2021;7(11):2959\u201370. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00424.","journal-title":"ACS Infect Dis"},{"issue":"3","key":"5368_CR17","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1002\/agt2.309","volume":"4","author":"Z Sun","year":"2023","unstructured":"Sun Z, Ma L, Sun X, Sloan AJ, O\u2019Brien-Simpson NM, Li W. The overview of antimicrobial peptide\u2010coated implants against oral bacterial infections. Aggregate. 2023;4(3):e309. https:\/\/doi.org\/10.1002\/agt2.309.","journal-title":"Aggregate"},{"issue":"1","key":"5368_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/abr.abr_38_20","volume":"9","author":"PH Abharian","year":"2020","unstructured":"Abharian PH, Dehghan P, Hassani-Abharian P, Jabalameli Z. Frequency of Candida species in the oral cavity of narcotics and stimulants smokers in Isfahan, using polymerase chain reaction-restriction fragment length polymorphism method. Adv Biomed Res. 2020;9(1):30. https:\/\/doi.org\/10.4103\/abr.abr_38_20.","journal-title":"Adv Biomed Res"},{"issue":"2","key":"5368_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1099\/jmm.0.46155-0","volume":"55","author":"S Fanello","year":"2006","unstructured":"Fanello S, Bouchara J, Sauteron M, Delbos V, Parot E, Marot-Leblond A, Moalic E, Flohicc AL, Brangerd B. Predictive value of oral colonization by Candida yeasts for the onset of a nosocomial infection in elderly hospitalized patients. J Med Microbiol. 2006;55(2):223\u20138. https:\/\/doi.org\/10.1099\/jmm.0.46155-0.","journal-title":"J Med Microbiol"},{"issue":"7","key":"5368_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3109\/13693786.2013.800239","volume":"51","author":"J Eddouzi","year":"2013","unstructured":"Eddouzi J, Lohberger A, Vogne C, Manai M, Sanglard D. Identification and antifungal susceptibility of a large collection of yeast strains isolated in Tunisian hospitals. Med Mycol. 2013;51(7):737\u201346. https:\/\/doi.org\/10.3109\/13693786.2013.800239.","journal-title":"Med Mycol"},{"issue":"11","key":"5368_CR21","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1128\/JCM.02248-12","volume":"50","author":"E Cendejas-Bueno","year":"2012","unstructured":"Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M, Cuenca-Estrella M, G\u00f3mez-L\u00f3pez A, Boekhout T. Reclassification of the Candida Haemulonii complex as Candida Haemulonii (C. Haemulonii group I), C. duobushaemulonii sp. nov.(C. Haemulonii group II), and C. Haemulonii var. Vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol. 2012;50(11):3641\u201351. https:\/\/doi.org\/10.1128\/JCM.02248-12.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"5368_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.18869\/acadpub.cmm.1.3.11","volume":"1","author":"F Katiraee","year":"2015","unstructured":"Katiraee F, Teifoori F, Soltani M. Emergence of azole-resistant Candida species in AIDS patients with oropharyngeal candidiasis in Iran. Curr Med Mycol. 2015;1(3):11. https:\/\/doi.org\/10.18869\/acadpub.cmm.1.3.11.","journal-title":"Curr Med Mycol"},{"key":"5368_CR23","doi-asserted-by":"publisher","unstructured":"Arastehfar A, Daneshnia F, Zomorodian K, Najafzadeh MJ, Khodavaisy S, Zarrinfar H, Hagen F, Zare Shahrabadi Z, Lackner M, Mirhendi H. Low level of antifungal resistance in Iranian isolates of Candida Glabrata recovered from blood samples in a multicenter study from 2015 to 2018 and potential prognostic values of genotyping and sequencing of PDR1. Antimicrob Agents Chemother. 2019;63(7):10.1128\/aac. https:\/\/doi.org\/10.1128\/AAC.02503-18.","DOI":"10.1128\/AAC.02503-18"},{"issue":"3","key":"5368_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.18502\/cmm.7.3.7801","volume":"7","author":"H Zarrinfar","year":"2021","unstructured":"Zarrinfar H, Kord Z, Fata A. High incidence of azole resistance among Candida albicans and C. Glabrata isolates in northeastern Iran. Curr Med Mycol. 2021;7(3):18. https:\/\/doi.org\/10.18502\/cmm.7.3.7801.","journal-title":"Curr Med Mycol"},{"issue":"6","key":"5368_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.7883\/yoken.JJID.2005.344","volume":"58","author":"MR Capoor","year":"2005","unstructured":"Capoor MR, Nair D, Deb M, Verma PK, Srivastava L, Aggarwal P. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. Jpn J Infect Dis. 2005;58(6):344\u20138.","journal-title":"Jpn J Infect Dis"},{"issue":"6","key":"5368_CR26","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/jac\/dkv445","volume":"71","author":"A Ko\u0142aczkowska","year":"2016","unstructured":"Ko\u0142aczkowska A, Ko\u0142aczkowski M. Drug resistance mechanisms and their regulation in non-albicans Candida species. J Antimicrob Chemother. 2016;71(6):1438\u201350. https:\/\/doi.org\/10.1093\/jac\/dkv445.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"5368_CR27","doi-asserted-by":"publisher","first-page":"e02539","DOI":"10.1128\/spectrum.02539-21","volume":"10","author":"P Badiee","year":"2022","unstructured":"Badiee P, Boekhout T, Zarei Mahmoudabadi A, Mohammadi R, Ayatollahi Mousavi SA, Najafzadeh MJ, Soltani J, Hashemi J, Diba K, Ghadimi-Moghadam A. Multicenter study of susceptibility of aspergillus species isolated from Iranian university hospitals to seven antifungal agents. Microbiol Spectr. 2022;10(3):e02539\u201321. https:\/\/doi.org\/10.1128\/spectrum.02539-21.","journal-title":"Microbiol Spectr"},{"key":"5368_CR28","doi-asserted-by":"publisher","first-page":"805527","DOI":"10.3389\/fped.2021.805527","volume":"9","author":"Z Rafat","year":"2021","unstructured":"Rafat Z, Sasani E, Salimi Y, Hajimohammadi S, Shenagari M, Roostaei D. The prevalence, etiological agents, clinical features, treatment, and diagnosis of HIV-associated oral candidiasis in pediatrics across the world: a systematic review and meta-analysis. Front Pediatr. 2021;9:805527. https:\/\/doi.org\/10.3389\/fped.2021.805527.","journal-title":"Front Pediatr"},{"issue":"4","key":"5368_CR29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/lam.13052","volume":"67","author":"S Khedri","year":"2018","unstructured":"Khedri S, Santos A, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S. Iranian HIV\/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. Lett Appl Microbiol. 2018;67(4):392\u20139. https:\/\/doi.org\/10.1111\/lam.13052.","journal-title":"Lett Appl Microbiol"},{"issue":"2","key":"5368_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.diagmicrobio.2018.09.007","volume":"93","author":"A Arastehfar","year":"2019","unstructured":"Arastehfar A, Fang W, Pan W, Lackner M, Liao W, Badiee P, Zomorodian K, Badali H, Hagen F, Lass-Fl\u00f6rl C. YEAST PANEL multiplex PCR for identification of clinically important yeast species: stepwise diagnostic strategy, useful for developing countries. Diagn Microbiol Infect Dis. 2019;93(2):112\u20139. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.09.007.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5368_CR31","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts. CLSI standard M27","author":"CLSI","year":"2017","unstructured":"CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts. CLSI standard M27. 4th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.","edition":"4"},{"key":"5368_CR32","unstructured":"CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts. Fourth informational supplement CLSI document M27-S4 (Draft 4) Wayne, PA Clinical and Laboratory Standards Institute 2012.2012."},{"key":"5368_CR33","unstructured":"M60. Psfastoy: 1st edn. Wayne, PA: Clinical and Laboratory Standards Institute 2017."},{"key":"5368_CR34","unstructured":"CLSI.: Epidemiological cut-off values for antifungal susceptibility testing. CLSI supplement M59 2nd edn Wayne, PA: Clinical and Laboratory Standards Institute. 2018. 2018."},{"key":"5368_CR35","doi-asserted-by":"crossref","unstructured":"Golirad N, Fozouni L, Pordeli H. Evaluation of susceptibility to fluconazole and voriconazole in oral Candida Glabrata isolates from drug addicts. Int J High Risk Behav Addict. 2019;8(4).","DOI":"10.5812\/ijhrba.92807"},{"issue":"2","key":"5368_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.22122\/ahj.v13i2.301","volume":"13","author":"N Navabi","year":"2021","unstructured":"Navabi N, Ayatollahi-Mousavi SA, Anvari N. A comparison of the prevalence rate of oral Candida colonization between Opium users and cigarette smokers in Kerman, Iran. Addict Health. 2021;13(2):106. https:\/\/doi.org\/10.22122\/ahj.v13i2.301.","journal-title":"Addict Health"},{"issue":"4","key":"5368_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/lam.12620","volume":"63","author":"C Sheth","year":"2016","unstructured":"Sheth C, Makda K, Dilmahomed Z, Gonz\u00e1lez R, Luzi A, Jovani-Sancho MdM, Veses V. Alcohol and tobacco consumption affect the oral carriage of Candida albicans and mutans Streptococci. Lett Appl Microbiol. 2016;63(4):254\u20139. https:\/\/doi.org\/10.1111\/lam.12620.","journal-title":"Lett Appl Microbiol"},{"issue":"3","key":"5368_CR38","first-page":"20","volume":"7","author":"A Berberi","year":"2015","unstructured":"Berberi A, Noujeim Z, Aoun G. Epidemiology of oropharyngeal candidiasis in human immunodeficiency virus\/acquired immune deficiency syndrome patients and CD4\u2009+\u2009counts. J Int Oral Health. 2015;7(3):20.","journal-title":"J Int Oral Health"},{"issue":"9","key":"5368_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.4103\/1995-7645.356992","volume":"15","author":"A Ghojoghi","year":"2022","unstructured":"Ghojoghi A, Erfaninejad M, Ahmadpour E, Nazar E, Barac A, Fatahinia M. Non-albicans candidemia in cancer patients as an increasing health problem: a comprehensive review and meta-analysis. Asian Pac J Trop Med. 2022;15(9):387\u201399. https:\/\/doi.org\/10.4103\/1995-7645.356992.","journal-title":"Asian Pac J Trop Med"},{"issue":"4","key":"5368_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5455\/msm.2013.25.223-225","volume":"25","author":"S Hadzic","year":"2013","unstructured":"Hadzic S, Dedic A, Gojkov-Vukelic M, Mehic-Basara N, Hukic M, Babic M, Beslagic E. The effect of psychoactive substances (drugs) on the presence and frequency of oral Candida species and Candida Dubliniensis. Mater Sociomed. 2013;25(4):223. https:\/\/doi.org\/10.5455\/msm.2013.25.223-225.","journal-title":"Mater Sociomed"},{"key":"5368_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1590\/S0036-46652012000100004","volume":"54","author":"JC Junqueira","year":"2012","unstructured":"Junqueira JC, Vilela SF, Rossoni RD, Barbosa JO, Costa ACB, Rasteiro V, Suleiman JM, Jorge AOC. Oral colonization by yeasts in HIV-positive patients in Brazil. Rev Inst Med Trop Sao Paulo. 2012;54:17\u201324.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"3","key":"5368_CR42","doi-asserted-by":"publisher","first-page":"ovad029","DOI":"10.1093\/lambio\/ovad029","volume":"76","author":"M Erfaninejad","year":"2023","unstructured":"Erfaninejad M, Zarei Mahmoudabadi A, Maraghi E, Hashemzadeh M, Fatahinia M. Low level of antifungal resistance in Candida species recovered from Iranian HIV-associated oral infection. Lett Appl Microbiol. 2023;76(3):ovad029. https:\/\/doi.org\/10.1093\/lambio\/ovad029.","journal-title":"Lett Appl Microbiol"},{"issue":"1","key":"5368_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/jof7010013","volume":"7","author":"N Medina","year":"2020","unstructured":"Medina N, Soto-Debr\u00e1n JC, Seidel D, Akyar I, Badali H, Barac A, Bretagne S, Cag Y, Cassagne C, Castro C. MixInYeast: a multicenter study on mixed yeast infections. J Fungi. 2020;7(1):13. https:\/\/doi.org\/10.3390\/jof7010013.","journal-title":"J Fungi"},{"issue":"1","key":"5368_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4103\/abr.abr_214_19","volume":"9","author":"M Maheronnaghsh","year":"2020","unstructured":"Maheronnaghsh M, Fatahinia M, Dehghan P, Teimoori A. Identification of Candida species and antifungal susceptibility in cancer patients with oral lesions in Ahvaz, Southern West of Iran. Adv Biomed Res. 2020;9(1):50. https:\/\/doi.org\/10.4103\/abr.abr_214_19.","journal-title":"Adv Biomed Res"},{"key":"5368_CR45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fmicb.2017.00298","volume":"8","author":"AL Ter\u00e7as","year":"2017","unstructured":"Ter\u00e7as AL, Marques SG, Moffa EB, Alves MB, de Azevedo CM, Siqueira WL, Monteiro CA. Antifungal drug susceptibility of Candida species isolated from HIV-positive patients recruited at a public hospital in S\u00e3o Lu\u00eds, Maranh\u00e3o, Brazil. Front Microbiol. 2017;8:298. https:\/\/doi.org\/10.3389\/fmicb.2017.00298.","journal-title":"Front Microbiol"},{"issue":"4","key":"5368_CR46","first-page":"282","volume":"13","author":"P Badiei","year":"2010","unstructured":"Badiei P, Alborzi A, Davarpanah MA, Shakiba E. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch Iran Med. 2010;13(4):282\u20137.","journal-title":"Arch Iran Med"},{"key":"5368_CR47","doi-asserted-by":"publisher","unstructured":"Borman AM, Muller J, Walsh-Quantick J, Szekely A, Patterson Z, Palmer MD, Fraser M, Johnson EM. Fluconazole resistance in isolates of uncommon pathogenic yeast species from the United Kingdom. Antimicrob Agents Chemother. 2019;63(8). https:\/\/doi.org\/10.1128\/aac. 00211\u2009\u2013\u200919.","DOI":"10.1128\/aac"},{"issue":"5","key":"5368_CR48","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/jac\/dkz568","volume":"75","author":"AM Borman","year":"2020","unstructured":"Borman AM, Muller J, Walsh-Quantick J, Szekely A, Patterson Z, Palmer MD, Fraser M, Johnson EM. MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method. J Antimicrob Chemother. 2020;75(5):1194\u2013205. https:\/\/doi.org\/10.1093\/jac\/dkz568.","journal-title":"J Antimicrob Chemother"},{"key":"5368_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2916-5","volume":"18","author":"N Aslani","year":"2018","unstructured":"Aslani N, Janbabaei G, Abastabar M, Meis JF, Babaeian M, Khodavaisy S, Boekhout T, Badali H. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry. BMC Infect Dis. 2018;18:1\u201311. https:\/\/doi.org\/10.1186\/s12879-017-2916-5.","journal-title":"BMC Infect Dis"},{"key":"5368_CR50","doi-asserted-by":"publisher","unstructured":"Kaplan E, Al-Hatmi AM, Ilkit M, van den Gerrits A, Hagen F, Meis JF, De Hoog GS. Molecular diagnostics of arthroconidial yeasts, frequent pulmonary opportunists. J Clin Microbiol. 2018;56(1):10.1128\/jcm. 01427-17. https:\/\/doi.org\/10.1128\/JCM.01427-17.","DOI":"10.1128\/JCM.01427-17"},{"issue":"2","key":"5368_CR51","first-page":"269","volume":"43","author":"B Sancak","year":"2009","unstructured":"Sancak B, Alp S, Hascelik G, Arikan S. Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces Capitatus (Geotrichum Capitatum) by two different methods. Mikrobiyol Bul. 2009;43(2):269\u201376.","journal-title":"Mikrobiyol Bul"},{"issue":"1","key":"5368_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.18502\/cmm.5.1.533","volume":"5","author":"S Paul","year":"2019","unstructured":"Paul S, Kannan I. Molecular identification and antifungal susceptibility pattern of Candida species isolated from HIV infected patients with candisiasis. Curr Med Mycol. 2019;5(1):21. https:\/\/doi.org\/10.18502\/cmm.5.1.533.","journal-title":"Curr Med Mycol"},{"issue":"4","key":"5368_CR53","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/myc.12595","volume":"60","author":"L Dur\u00e1n Graeff","year":"2017","unstructured":"Dur\u00e1n Graeff L, Seidel D, Vehreschild MJ, Hamprecht A, Kindo A, Racil Z, Demeter J, De Hoog S, Aurbach U, Ziegler M. Invasive infections due to Saprochaete and Geotrichum species: report of 23 cases from the FungiScope Registry. Mycoses. 2017;60(4):273\u20139. https:\/\/doi.org\/10.1111\/myc.12595.","journal-title":"Mycoses"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-05368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-024-05368-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-05368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T16:03:10Z","timestamp":1735228990000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-024-05368-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5368"],"URL":"https:\/\/doi.org\/10.1186\/s12903-024-05368-2","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Research Ethics Committee of Ahvaz Jundishapur University of Medical Sciences, with the ethical code number IR.AJUMS.MEDICINE.REC.1400.047. All participants in our study provided informed consent prior to their inclusion. The participants signed an informed consent form, and we adhered to all relevant guidelines and regulations throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1555"}}